Herbas VPB

Print
EN | LT
LT - OPTIMIERTE INJEKTIONSLÖSUNG FÜR MRNA
EN - OPTIMISED INJECTION FORMULATION FOR MRNA

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 47/02 (2006.01)
A61K 9/0019 (2013.01)
A61K 47/12 (2006.01)
A61K 31/7088 (2013.01)
A61K 9/00 (2006.01)
A61K 31/7105 (2013.01)
A61K 47/02 (2013.01)
A61K 31/7088 (2006.01)
C12N 15/87 (2006.01)
A61K 47/12 (2013.01)
A61K 48/00 (2006.01)
A61K 48/0008 (2013.01)
A61K 48/005 (2013.01)
A61K2039/53 (2013.01)
A61K 39/00 (2013.01)
A61P 35/00 (2018.01)
A61P 37/02 (2018.01)
A61P 37/08 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3583953
(13) Kind of document T
(96) European patent application number 19176589.0
Date of filing the European patent application 2006-05-19
(97) Date of publication of the European application 2019-12-25
(45) Date of publication and mention of the grant of the patent 2023-06-28
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
102005023170 2005-05-19 DE
Inventors
(72)
HOERR, Ingmar , DE
PASCOLO, Steve , DE
Grantee
(73) CureVac SE , Friedrich-Miescher-Straße 15, 72076 Tübingen, DE
Title
(54) OPTIMIERTE INJEKTIONSLÖSUNG FÜR MRNA
  OPTIMISED INJECTION FORMULATION FOR MRNA